Antigen Discovery

GenVec's patented antigen discovery system, based on customized arrays of our proprietary adenovectors, is designed to efficiently identify new antigens capable of inducing the immune responses needed to protect against disease. We recently presented a demonstration of this approach, in which our antigen discovery system was utilized to identify several novel and highly protective antigens for malaria. Our adenovector array discovery system is yet another component of GenVec's AdenoVerse™ technology platform, which can be customized to identify the new genes and antigens needed for successful gene-based medicines.